Welcome to the Oncomine Blog

The Impact of NGS in Hematology-Oncology

08/19/2020

In aggressive forms of cancer such as acute myeloid leukemia (AML), accurate diagnosis is needed as soon as possible. Targeted therapies can offer better chances for patients with certain abnormalities or biomarkers, and next-generation sequencing..

The Importance of Detecting Copy Number Variants ...

Structural variants in the cancer genome Gene amplification (copy number gain) and deletion (copy ...

Breakthrough Device Designation for Oncomine Dx ...

Philip Scard knew immediately and intimately that the June 15 news release from Thermo Fisher ...

The OncomineWorld Experience from Behind the ...

BACKGROUND:  There is little to no point in saying that we are all living in an unprecedented time, ...

Comprehensive Biomarker Testing Reveals RET ...

It’s been a tough road for Melissa Crouse, sometimes almost deadly. She had a lobe of her left lung ...

Building a Case for In-House Next Generation ...

Diagnostics lab team demonstrates how insourcing NGS makes sound financial sense and helps deliver ...

Q2 Solutions Eyes Genexus System as its ...

When it comes to supporting clinical trials, having a global footprint is simply not enough for ...

Shifting the Paradigm: Broader Patient Access to ...

We are living in an unprecedented time in the collective fight against cancer, where recent ...

The Importance of Detecting the Most Fusions ...

In recent years, we’ve seen an increasing number of new therapies emerge that target gene fusions ...


Stay Up-To-Date

Connect project to a Slack channel and everyone in the team will be notified

Subscribe